Logo image of MGRM

MONOGRAM TECHNOLOGIES INC (MGRM) Stock Fundamental Analysis

USA - NASDAQ:MGRM - US6097861081 - Common Stock

6 USD
-0.11 (-1.8%)
Last: 10/6/2025, 8:42:04 PM
6.2 USD
+0.2 (+3.33%)
After Hours: 10/6/2025, 8:42:04 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MGRM. MGRM was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While MGRM has a great health rating, there are worries on its profitability. MGRM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MGRM had negative earnings in the past year.
In the past year MGRM has reported a negative cash flow from operations.
MGRM had negative earnings in each of the past 5 years.
In the past 5 years MGRM always reported negative operating cash flow.
MGRM Yearly Net Income VS EBIT VS OCF VS FCFMGRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

MGRM has a Return On Assets of -123.05%. This is amonst the worse of the industry: MGRM underperforms 80.10% of its industry peers.
MGRM's Return On Equity of -214.17% is on the low side compared to the rest of the industry. MGRM is outperformed by 73.30% of its industry peers.
Industry RankSector Rank
ROA -123.05%
ROE -214.17%
ROIC N/A
ROA(3y)-91.88%
ROA(5y)-104.59%
ROE(3y)-182.06%
ROE(5y)-213.04%
ROIC(3y)N/A
ROIC(5y)N/A
MGRM Yearly ROA, ROE, ROICMGRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

MGRM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MGRM Yearly Profit, Operating, Gross MarginsMGRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

8

2. Health

2.1 Basic Checks

MGRM does not have a ROIC to compare to the WACC, probably because it is not profitable.
MGRM has less shares outstanding than it did 1 year ago.
MGRM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MGRM Yearly Shares OutstandingMGRM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
MGRM Yearly Total Debt VS Total AssetsMGRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

MGRM has an Altman-Z score of 13.55. This indicates that MGRM is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.55, MGRM belongs to the top of the industry, outperforming 92.67% of the companies in the same industry.
There is no outstanding debt for MGRM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.55
ROIC/WACCN/A
WACC8.77%
MGRM Yearly LT Debt VS Equity VS FCFMGRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

MGRM has a Current Ratio of 2.16. This indicates that MGRM is financially healthy and has no problem in meeting its short term obligations.
MGRM has a Current ratio of 2.16. This is comparable to the rest of the industry: MGRM outperforms 40.31% of its industry peers.
A Quick Ratio of 2.16 indicates that MGRM has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.16, MGRM is in line with its industry, outperforming 57.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 2.16
MGRM Yearly Current Assets VS Current LiabilitesMGRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

1

3. Growth

3.1 Past

MGRM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -45.02%.
Looking at the last year, MGRM shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-45.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.45%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

MGRM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.33% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y2%
EPS Next 2Y11.8%
EPS Next 3Y-1.32%
EPS Next 5Y19.33%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MGRM Yearly Revenue VS EstimatesMGRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2023 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
MGRM Yearly EPS VS EstimatesMGRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 0.5 -0.5 1 1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

MGRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MGRM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MGRM Price Earnings VS Forward Price EarningsMGRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MGRM Per share dataMGRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.8%
EPS Next 3Y-1.32%

More info and screens

0

5. Dividend

5.1 Amount

MGRM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONOGRAM TECHNOLOGIES INC

NASDAQ:MGRM (10/6/2025, 8:42:04 PM)

After market: 6.2 +0.2 (+3.33%)

6

-0.11 (-1.8%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-14 2025-11-14
Inst Owners4.97%
Inst Owner Change0%
Ins Owners19.29%
Ins Owner Change0%
Market Cap243.78M
Analysts82.86
Price Target8.57 (42.83%)
Short Float %0.87%
Short Ratio1.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.93%
Min EPS beat(2)-42.6%
Max EPS beat(2)14.75%
EPS beat(4)1
Avg EPS beat(4)-18.61%
Min EPS beat(4)-42.6%
Max EPS beat(4)14.75%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)47.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.74%
EPS NY rev (1m)0%
EPS NY rev (3m)18.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 28.29
P/tB 29.08
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.31
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -123.05%
ROE -214.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-91.88%
ROA(5y)-104.59%
ROE(3y)-182.06%
ROE(5y)-213.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 94.16%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.16
Quick Ratio 2.16
Altman-Z 13.55
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)32.55%
Cap/Depr(5y)360.85%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-45.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-45.45%
EPS Next Y2%
EPS Next 2Y11.8%
EPS Next 3Y-1.32%
EPS Next 5Y19.33%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.12%
EBIT Next 3Y13.22%
EBIT Next 5Y28.6%
FCF growth 1Y-1.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y0.16%
OCF growth 3YN/A
OCF growth 5YN/A